Vimarsana
Biggest News Aggregation in the World

Page 17 - Corp Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Corp Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Corp Communications Today - Breaking & Trending Today

Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results - Vimarsana News

Nevro to Report Fourth Quarter and Full-Year 2020 Financial Results

Share this article Share this article REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter and full-year ended December 31, 2020 after the market closes on February 24, 2021. Management will host a conference call on February 24, 2021 to discuss fourth quarter and full-year 2020 financial results. The call will begin at 1:30 pm PT/ 4:30 pm ET.  Investors i...

Mydecine Innovations Group Files Application to list to the NASDAQ - Vimarsana News

Mydecine Innovations Group Files Application to list to the NASDAQ

Mydecine Innovations Group Files Application to list to the NASDAQ Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has submitted a formal application to list its common shares on the NASDAQ Stock Exchange . NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world’s best … Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging...

Mydecine Innovations Group Included in First-Ever Psychedelics ETF - Vimarsana News

Mydecine Innovations Group Included in First-Ever Psychedelics ETF

Mydecine Innovations Group Included in First-Ever Psychedelics ETF Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, has been included in the first-ever Psychedelics Exchanged Traded Fund . The Horizons Psychedelic Stock Index ETF index, which was announced in December 2020 and includes 17 companies in the U.S. and Canada, is expected to start … Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emer...

Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference - Vimarsana News

Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference

Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference Friday, January 15, 2021, at 4:00 pm Pacific Time / 6:00 pm Central Time News provided by Share this article Share this article REDWOOD CITY, Calif., Dec. 22, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it will host and webcast a virtual investor briefing at the 2021 North American Neuromodulation Society (NANS) Virtual Conference on Friday...